NO934383L - Roentgenkontrastmiddel - Google Patents

Roentgenkontrastmiddel

Info

Publication number
NO934383L
NO934383L NO934383A NO934383A NO934383L NO 934383 L NO934383 L NO 934383L NO 934383 A NO934383 A NO 934383A NO 934383 A NO934383 A NO 934383A NO 934383 L NO934383 L NO 934383L
Authority
NO
Norway
Prior art keywords
roentgenkontrastmiddel
Prior art date
Application number
NO934383A
Other languages
English (en)
Other versions
NO308126B1 (no
NO934383D0 (no
Inventor
Bengt Hersloef
Kaare Larsson
Stig Bengmark
Original Assignee
Karlshamns Lipid Teknik Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to SE9101709A priority Critical patent/SE9101709L/
Priority to PCT/SE1992/000374 priority patent/WO1992021384A1/en
Application filed by Karlshamns Lipid Teknik Ab filed Critical Karlshamns Lipid Teknik Ab
Publication of NO934383L publication Critical patent/NO934383L/no
Publication of NO934383D0 publication Critical patent/NO934383D0/no
Publication of NO308126B1 publication Critical patent/NO308126B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461Dispersions, colloids, emulsions or suspensions
    • A61K49/0466Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles
NO934383A 1991-06-03 1993-12-02 Fosfolipidbasert forbindelse, anvendelse derav samt røntgenkontrastmiddel NO308126B1 (no)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE9101709A SE9101709L (sv) 1991-06-03 1991-06-03 LIPID DERIVATIVES AS DIAGNOSTIC OR CONTRACTANT
PCT/SE1992/000374 WO1992021384A1 (en) 1991-06-03 1992-06-03 X-ray contrast agent

Publications (3)

Publication Number Publication Date
NO934383L true NO934383L (no) 1993-12-02
NO934383D0 NO934383D0 (no) 1993-12-02
NO308126B1 NO308126B1 (no) 2000-07-31

Family

ID=20382938

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934383A NO308126B1 (no) 1991-06-03 1993-12-02 Fosfolipidbasert forbindelse, anvendelse derav samt røntgenkontrastmiddel

Country Status (13)

Country Link
US (1) US5550263A (no)
EP (1) EP0588869B1 (no)
JP (1) JP3013939B2 (no)
AT (1) AT185490T (no)
AU (1) AU652260B2 (no)
CA (1) CA2103462C (no)
DE (1) DE69230144T2 (no)
DK (1) DK0588869T3 (no)
ES (1) ES2140409T3 (no)
FI (1) FI935386A (no)
NO (1) NO308126B1 (no)
SE (1) SE9101709L (no)
WO (1) WO1992021384A1 (no)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6217849B1 (en) * 1993-09-29 2001-04-17 Bracco Research S.A. Liposome suspensions as blood pool imaging contrast agents
SE470086B (sv) * 1991-04-23 1993-11-08 Kabi Pharmacia Ab Organ-specific emulsion
US5851510A (en) * 1994-05-16 1998-12-22 The Board Of Regents Of The University Of Michigan Hepatocyte-selective oil-in-water emulsion
GB9420390D0 (en) * 1994-10-10 1994-11-23 Nycomed Salutar Inc Liposomal agents
KR100824068B1 (ko) * 2000-04-28 2008-04-21 후지필름 홀딩스 가부시끼가이샤 소수성 요오드 화합물을 함유하는 리포솜
DE60222843T2 (de) 2001-08-20 2008-07-17 Fujifilm Corporation Hydrophobe Iodverbindung enthaltendes Liposom und dieses enthaltendes Röntgenkontrastmittel
US20040018237A1 (en) 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
US7498018B2 (en) * 2003-10-03 2009-03-03 Bracco Diagnostics Inc. Contrast media for use in medical and diagnostic procedures and methods of using the same
DE102004049652A1 (de) * 2004-10-11 2006-04-20 Degussa Ag Leitungssystem für Fluide und Gase in einer Brennstoffzelle
WO2007129311A2 (en) * 2006-05-04 2007-11-15 Pan Sci Tech S.A. Nano-particles with contrast agents for diagnostic delivery system for x-ray and ct
CN103547258B (zh) 2011-03-17 2017-10-20 特兰斯德梅尔生物工艺股份有限公司 局部一氧化氮系统及其使用方法
EP2532649B1 (en) * 2011-06-07 2015-04-08 Incella GmbH Amino lipids, their synthesis and uses thereof
WO2013121284A1 (en) * 2012-02-14 2013-08-22 Universite De Strasbourg Iodinated products intended for a use for the medical imaging and their methods of preparation
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US20140276021A1 (en) * 2013-03-15 2014-09-18 The Regents Of The University Of California Enteric ct contrast material based on low-z atoms

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235792A (en) * 1977-04-14 1980-11-25 The Governing Council Of The University Of Toronto Immunological materials
US4192859A (en) * 1978-09-29 1980-03-11 E. R. Squibb & Sons, Inc. Contrast media containing liposomes as carriers
CH641682A5 (en) * 1978-10-05 1984-03-15 Daeniker Felix X-ray contrast medium
US4386078A (en) * 1980-03-03 1983-05-31 The Ohio State University Research Foundation Therapeutic agents for preventing phospholipid degradation and free fatty acid proliferation
US4480041A (en) * 1982-07-09 1984-10-30 Collaborative Research, Inc. Use of phosphotriester intermediates for preparation of functionalized liposomes
JPH0378115B2 (no) * 1983-04-11 1991-12-12 Meito Sangyo Kk
EP0262876B1 (en) * 1986-09-27 1992-04-29 Toyo Jozo Kabushiki Kaisha Nucleoside-phospholipid conjugate
JPH0322591B2 (no) * 1987-03-20 1991-03-27 Tohoku Denshi Sangyo Kk
CH672733A5 (no) * 1987-05-22 1989-12-29 Bracco Ind Chimica Spa
CA1340413C (en) * 1987-09-09 1999-03-02 Chiron Diagnostics Corporation Method of preparing phosphodiester conjugates useful for immunoactive liposomes

Also Published As

Publication number Publication date
DK588869T3 (no)
EP0588869A1 (en) 1994-03-30
WO1992021384A1 (en) 1992-12-10
SE9101709D0 (sv) 1991-06-03
US5550263A (en) 1996-08-27
FI935386A (fi) 1993-12-01
DE69230144D1 (de) 1999-11-18
NO308126B1 (no) 2000-07-31
JP3013939B2 (ja) 2000-02-28
CA2103462C (en) 1998-03-31
FI935386D0 (no)
DE69230144T2 (de) 2000-05-25
EP0588869B1 (en) 1999-10-13
ES2140409T3 (es) 2000-03-01
AU1903392A (en) 1993-01-08
AU652260B2 (en) 1994-08-18
CA2103462A1 (en) 1992-12-04
DK0588869T3 (da) 2000-04-17
AT185490T (de) 1999-10-15
NO934383D0 (no) 1993-12-02
FI935386A0 (fi) 1993-12-01
JPH06510276A (no) 1994-11-17
SE9101709L (sv) 1992-12-04

Similar Documents

Publication Publication Date Title
NO305379B1 (no) OvervÕkningssystem
NO920492D0 (no) BARBERHOEVEL
NO2001003I1 (no) Gadovist
NO180424C (no) Skyvkraft-dirigerende avgassdyse
NO923345D0 (no) Vevnad
NO913680L (no) Stoevsugerpose
NO912054L (no) Haarfargepreparat
NO924673D0 (no) Forbedret stoepeformtetning for oeyelinser
ITMI921588A1 (it) Bisbenzofuran-2-oni
ITMI922173D0 (it) Alchil-bisacilfosfinossidi
NO179545B (no) Konstruksjonsleketöysystem
NO301604B1 (no) Bærekonstruksjon
NO173261B (no) Intravenoeskanyle
NO2009019I1 (no) Amiodipinbesylat
NO174120B (no) Proeveinnretning for trykkmaalere
NO923223D0 (no) Hellende blandeboette
NO934383D0 (no) R!ntgenkontrastmiddel
NO177486B (no) Filterpartron
NO924172D0 (no) Substituerte bifenylpyridoner
NO931722D0 (no) Injeksjonsnaalanordning
NO942027D0 (no) Kjönnssteroidaktivitetshemmere
NO934500D0 (no) Ikke-klorfluorcarbonaerosolformuleringer
NO922111D0 (no) Rapamycin dimer
NO923898L (no) Laasemutter
NO920333D0 (no) ROENTGENKONTRASTPREPARATER

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN DECEMBER 2001